Roberta Torcasio
Catanzaro, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correction: Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax.
Journal: Journal of translational medicine
Published: November 11, 2025
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax.
Journal: Journal of translational medicine
Published: July 01, 2025
Cytogenetic and molecular characterization of an atypical ETP-ALL case with BCL2 dependency: therapeutic implications for Venetoclax use.
Journal: Molecular biology reports
Published: June 26, 2025
Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistance.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: June 16, 2025
DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma.
Journal: Blood
Published: June 11, 2025
O-derivatization of natural tropolone and β-thujaplicin leading to effective inhibitors of human carbonic anhydrases IX and XII.
Journal: European journal of medicinal chemistry
Published: February 18, 2025
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma.
Journal: Haematologica
Published: February 14, 2025
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity.
Journal: Journal of translational medicine
Published: January 25, 2024
New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome Inhibitors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 25, 2023
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma.
Journal: Cells
Published: August 10, 2023
Lipid metabolic vulnerabilities of multiple myeloma.
Journal: Clinical and experimental medicine
Published: July 13, 2023
Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro Studies.
Journal: Antioxidants (Basel, Switzerland)
Published: April 14, 2023
Last Updated: 09/26/2026